These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 23707949

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of Wnt signaling suppression on gefitinib in non small cell lung cancer cell lines].
    Fang X, Gu P, Zhou CC, Ren SX, Luo BF, Zeng Y, Wu YJ, Zhao YM, Zhu XY, Yi XH.
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):455-9. PubMed ID: 24246864
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor.
    Murakami A, Takahashi F, Nurwidya F, Kobayashi I, Minakata K, Hashimoto M, Nara T, Kato M, Tajima K, Shimada N, Iwakami S, Moriyama M, Moriyama H, Koizumi F, Takahashi K.
    PLoS One; 2014 Jul; 9(1):e86459. PubMed ID: 24489728
    [Abstract] [Full Text] [Related]

  • 11. Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.
    Kobayashi I, Takahashi F, Nurwidya F, Nara T, Hashimoto M, Murakami A, Yagishita S, Tajima K, Hidayat M, Shimada N, Suina K, Yoshioka Y, Sasaki S, Moriyama M, Moriyama H, Takahashi K.
    Biochem Biophys Res Commun; 2016 Apr 22; 473(1):125-132. PubMed ID: 26996130
    [Abstract] [Full Text] [Related]

  • 12. [c-Met signaling pathway participating in the gefitinib resistance of different gene types of non-small cell lung cancer cells induced by HGF in vitro].
    Xuan X, An C, Zhou C.
    Zhongguo Fei Ai Za Zhi; 2013 Sep 22; 16(9):464-9. PubMed ID: 24034993
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3.
    Shou J, You L, Yao J, Xie J, Jing J, Jing Z, Jiang L, Sui X, Pan H, Han W.
    Cancer Lett; 2016 Aug 28; 379(1):124-33. PubMed ID: 27264264
    [Abstract] [Full Text] [Related]

  • 15. Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells.
    Lin Y, Higashisaka K, Shintani T, Maki A, Hanamuro S, Haga Y, Maeda S, Tsujino H, Nagano K, Fujio Y, Tsutsumi Y.
    Sci Rep; 2020 Mar 16; 10(1):4748. PubMed ID: 32179851
    [Abstract] [Full Text] [Related]

  • 16. Leucine Zipper Downregulated in Cancer-1 Interacts with Clathrin Adaptors to Control Epidermal Growth Factor Receptor (EGFR) Internalization and Gefitinib Response in EGFR-Mutated Non-Small Cell Lung Cancer.
    Huang HN, Hung PF, Chen YP, Lee CH.
    Int J Mol Sci; 2024 Jan 23; 25(3):. PubMed ID: 38338651
    [Abstract] [Full Text] [Related]

  • 17. Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor.
    Chang TH, Tsai MF, Su KY, Wu SG, Huang CP, Yu SL, Yu YL, Lan CC, Yang CH, Lin SB, Wu CP, Shih JY, Yang PC.
    Am J Respir Crit Care Med; 2011 Apr 15; 183(8):1071-9. PubMed ID: 21037017
    [Abstract] [Full Text] [Related]

  • 18. Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC.
    Terai H, Soejima K, Yasuda H, Nakayama S, Hamamoto J, Arai D, Ishioka K, Ohgino K, Ikemura S, Sato T, Yoda S, Satomi R, Naoki K, Betsuyaku T.
    Mol Cancer Res; 2013 Jul 15; 11(7):759-67. PubMed ID: 23536707
    [Abstract] [Full Text] [Related]

  • 19. miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124.
    Gao Y, Fan X, Li W, Ping W, Deng Y, Fu X.
    Biochem Biophys Res Commun; 2014 Mar 28; 446(1):179-86. PubMed ID: 24582749
    [Abstract] [Full Text] [Related]

  • 20. Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT.
    Yang J, Qin G, Luo M, Chen J, Zhang Q, Li L, Pan L, Qin S.
    Cell Death Dis; 2015 Jul 23; 6(7):e1829. PubMed ID: 26203858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.